115 related articles for article (PubMed ID: 8964901)
1. Characterization of a unique T-cell clone established from a patient with HAM/TSP which recognized HTLV-I-infected T-cell antigens as well as spinal cord tissue antigens.
Nagai M; Yashiki S; Fujiyoshi T; Fujiyama C; Kitze B; Izumo S; Osame M; Sonoda S
J Neuroimmunol; 1996 Apr; 65(2):97-105. PubMed ID: 8964901
[TBL] [Abstract][Full Text] [Related]
2. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Hara H; Morita M; Iwaki T; Hatae T; Itoyama Y; Kitamoto T; Akizuki S; Goto I; Watanabe T
J Exp Med; 1994 Sep; 180(3):831-9. PubMed ID: 8064235
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
[TBL] [Abstract][Full Text] [Related]
4. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy.
Kubota R; Umehara F; Izumo S; Ijichi S; Matsumuro K; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
J Neuroimmunol; 1994 Aug; 53(1):23-9. PubMed ID: 7914211
[TBL] [Abstract][Full Text] [Related]
5. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones.
Wucherpfennig KW; Höllsberg P; Richardson JH; Benjamin D; Hafler DA
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2110-4. PubMed ID: 1549569
[TBL] [Abstract][Full Text] [Related]
6. [Autoimmune mechanism in HAM/TSP].
Hara H
Nihon Rinsho; 1994 Nov; 52(11):2919-25. PubMed ID: 7996690
[TBL] [Abstract][Full Text] [Related]
7. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
[TBL] [Abstract][Full Text] [Related]
8. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
Best I; Adaui V; Verdonck K; González E; Tipismana M; Clark D; Gotuzzo E; Vanham G
Clin Exp Immunol; 2006 Nov; 146(2):226-33. PubMed ID: 17034574
[TBL] [Abstract][Full Text] [Related]
9. Autonomous proliferation of HTLV-CD4+ T cell clones derived from human T cell leukemia virus type I (HTLV-I)-associated myelopathy patients.
Miyano-Kurosaki N; Kira J; Barnor JS; Maeda N; Misawa N; Kawano Y; Tanaka Y; Yamamoto N; Koyanagi Y
Microbiol Immunol; 2007; 51(2):235-42. PubMed ID: 17310092
[TBL] [Abstract][Full Text] [Related]
10. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).
Osame M
J Neurovirol; 2002 Oct; 8(5):359-64. PubMed ID: 12402162
[TBL] [Abstract][Full Text] [Related]
11. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
12. Increase in T-cells bearing CD25 in bronchoalveolar lavage fluid from HAM/TSP patients and HTLV-I carriers.
Mukae H; Kohno S; Morikawa N; Kadota J; Matsukura S; Hara K
Microbiol Immunol; 1994; 38(1):55-62. PubMed ID: 8052162
[TBL] [Abstract][Full Text] [Related]
13. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
14. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
15. Abnormal in vitro proliferation and differentiation of T cell colony-forming cells in patients with tropical spastic paraparesis/human T lymphocyte virus type I (HTLV-I)-associated myeloencephalopathy and healthy HTLV-I carriers.
Lunardi-Iskandar Y; Gessain A; Lam VH; Gallo RC
J Exp Med; 1993 Mar; 177(3):741-50. PubMed ID: 8094736
[TBL] [Abstract][Full Text] [Related]
16. Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
Fukushima N; Nishiura Y; Nakamura T; Kohno S; Eguchi K
Intern Med; 2007; 46(7):347-51. PubMed ID: 17409595
[TBL] [Abstract][Full Text] [Related]
17. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
18. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
19. Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.
Santos SB; Porto AF; Muniz AL; Luna T; Nascimento MC; Guerreiro JB; Oliveira-Filho J; Morgan DJ; Carvalho EM
Neuroimmunomodulation; 2006; 13(3):145-51. PubMed ID: 17119343
[TBL] [Abstract][Full Text] [Related]
20. Identification and tracking of HTLV-1-infected T cell clones in virus-associated neurologic disease.
Nozuma S; Matsuura E; Tanaka M; Kodama D; Matsuzaki T; Yoshimura A; Sakiyama Y; Nakahata S; Morishita K; Enose-Akahata Y; Jacoboson S; Kubota R; Takashima H
JCI Insight; 2023 Apr; 8(7):. PubMed ID: 37036006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
